Molecular characterization of carbapenemase and cephalosporinase genes among clinical isolates of acinetobacter baumannii in a tertiary medical centre in Malaysia

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Antimicrobial resistance in Acinetobacter baumannii is a growing public health concern and an important pathogen in nosocomial infections. We investigated the genes involved in resistance to carbapenems and cephalosporins in clinical A. baumannii isolates from a tertiary medical centre in Malaysia. A. baumannii was isolated from 167 clinical specimens and identified by sequencing of the 16S rRNA and rpoB genes. The MIC for imipenem, meropenem, ceftazidime and cefepime were determined by the E-test method. The presence of carbapenemase and cephalosporinase genes was investigated by PCR. The isolates were predominantly nonsusceptible to carbapenems and cephalosporins (>70%) with high MIC values. ISAba1 was detected in all carbapenem-nonsusceptible A. baumannii harbouring the blaOXA-23-like gene. The presence of blaOXA-51-like and ISAba1 upstream of blaOXA-51 was not associated with nonsusceptibility to carbapenems. A. baumannii isolates harbouring ISAba1-blaADC (85.8%) were significantly associated with nonsusceptibility to cephalosporins (P< 0.0001). However, ISAba1-blaADC was not detected in a minority (< 10%) of the isolates which were nonsusceptible to cephalosporins. The acquired OXA-23 enzymes were responsible for nonsusceptibility to carbapenems in our clinical A. baumannii isolates and warrant continuous surveillance to prevent further dissemination of this antibiotic resistance gene. The presence of ISAba1 upstream of the blaADC was a determinant for cephalosporin resistance. However, the absence of this ISAba1-blaADC in some of the isolates may suggest other resistance mechanisms and need further investigation.

Original languageEnglish
Pages (from-to)53-58
Number of pages6
JournalJournal of Medical Microbiology
Volume64
Issue number1
DOIs
Publication statusPublished - 1 Jan 2015

Fingerprint

Cephalosporinase
Acinetobacter baumannii
Carbapenems
Malaysia
Cephalosporins
Genes
meropenem
Cephalosporin Resistance
Ceftazidime
Imipenem
Microbial Drug Resistance
Cross Infection
rRNA Genes
Public Health
carbapenemase
Polymerase Chain Reaction
Enzymes

ASJC Scopus subject areas

  • Microbiology (medical)
  • Microbiology
  • Medicine(all)

Cite this

@article{99e9baeef9b4449bb26a8cb104d35582,
title = "Molecular characterization of carbapenemase and cephalosporinase genes among clinical isolates of acinetobacter baumannii in a tertiary medical centre in Malaysia",
abstract = "Antimicrobial resistance in Acinetobacter baumannii is a growing public health concern and an important pathogen in nosocomial infections. We investigated the genes involved in resistance to carbapenems and cephalosporins in clinical A. baumannii isolates from a tertiary medical centre in Malaysia. A. baumannii was isolated from 167 clinical specimens and identified by sequencing of the 16S rRNA and rpoB genes. The MIC for imipenem, meropenem, ceftazidime and cefepime were determined by the E-test method. The presence of carbapenemase and cephalosporinase genes was investigated by PCR. The isolates were predominantly nonsusceptible to carbapenems and cephalosporins (>70{\%}) with high MIC values. ISAba1 was detected in all carbapenem-nonsusceptible A. baumannii harbouring the blaOXA-23-like gene. The presence of blaOXA-51-like and ISAba1 upstream of blaOXA-51 was not associated with nonsusceptibility to carbapenems. A. baumannii isolates harbouring ISAba1-blaADC (85.8{\%}) were significantly associated with nonsusceptibility to cephalosporins (P< 0.0001). However, ISAba1-blaADC was not detected in a minority (< 10{\%}) of the isolates which were nonsusceptible to cephalosporins. The acquired OXA-23 enzymes were responsible for nonsusceptibility to carbapenems in our clinical A. baumannii isolates and warrant continuous surveillance to prevent further dissemination of this antibiotic resistance gene. The presence of ISAba1 upstream of the blaADC was a determinant for cephalosporin resistance. However, the absence of this ISAba1-blaADC in some of the isolates may suggest other resistance mechanisms and need further investigation.",
author = "Shirin Biglari and Alfizah Hanafiah and Ramliza Ramli and Rahman, {Md. Mostafizur}",
year = "2015",
month = "1",
day = "1",
doi = "10.1099/jmm.0.082263-0",
language = "English",
volume = "64",
pages = "53--58",
journal = "Journal of Medical Microbiology",
issn = "0022-2615",
publisher = "Society for General Microbiology",
number = "1",

}

TY - JOUR

T1 - Molecular characterization of carbapenemase and cephalosporinase genes among clinical isolates of acinetobacter baumannii in a tertiary medical centre in Malaysia

AU - Biglari, Shirin

AU - Hanafiah, Alfizah

AU - Ramli, Ramliza

AU - Rahman, Md. Mostafizur

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Antimicrobial resistance in Acinetobacter baumannii is a growing public health concern and an important pathogen in nosocomial infections. We investigated the genes involved in resistance to carbapenems and cephalosporins in clinical A. baumannii isolates from a tertiary medical centre in Malaysia. A. baumannii was isolated from 167 clinical specimens and identified by sequencing of the 16S rRNA and rpoB genes. The MIC for imipenem, meropenem, ceftazidime and cefepime were determined by the E-test method. The presence of carbapenemase and cephalosporinase genes was investigated by PCR. The isolates were predominantly nonsusceptible to carbapenems and cephalosporins (>70%) with high MIC values. ISAba1 was detected in all carbapenem-nonsusceptible A. baumannii harbouring the blaOXA-23-like gene. The presence of blaOXA-51-like and ISAba1 upstream of blaOXA-51 was not associated with nonsusceptibility to carbapenems. A. baumannii isolates harbouring ISAba1-blaADC (85.8%) were significantly associated with nonsusceptibility to cephalosporins (P< 0.0001). However, ISAba1-blaADC was not detected in a minority (< 10%) of the isolates which were nonsusceptible to cephalosporins. The acquired OXA-23 enzymes were responsible for nonsusceptibility to carbapenems in our clinical A. baumannii isolates and warrant continuous surveillance to prevent further dissemination of this antibiotic resistance gene. The presence of ISAba1 upstream of the blaADC was a determinant for cephalosporin resistance. However, the absence of this ISAba1-blaADC in some of the isolates may suggest other resistance mechanisms and need further investigation.

AB - Antimicrobial resistance in Acinetobacter baumannii is a growing public health concern and an important pathogen in nosocomial infections. We investigated the genes involved in resistance to carbapenems and cephalosporins in clinical A. baumannii isolates from a tertiary medical centre in Malaysia. A. baumannii was isolated from 167 clinical specimens and identified by sequencing of the 16S rRNA and rpoB genes. The MIC for imipenem, meropenem, ceftazidime and cefepime were determined by the E-test method. The presence of carbapenemase and cephalosporinase genes was investigated by PCR. The isolates were predominantly nonsusceptible to carbapenems and cephalosporins (>70%) with high MIC values. ISAba1 was detected in all carbapenem-nonsusceptible A. baumannii harbouring the blaOXA-23-like gene. The presence of blaOXA-51-like and ISAba1 upstream of blaOXA-51 was not associated with nonsusceptibility to carbapenems. A. baumannii isolates harbouring ISAba1-blaADC (85.8%) were significantly associated with nonsusceptibility to cephalosporins (P< 0.0001). However, ISAba1-blaADC was not detected in a minority (< 10%) of the isolates which were nonsusceptible to cephalosporins. The acquired OXA-23 enzymes were responsible for nonsusceptibility to carbapenems in our clinical A. baumannii isolates and warrant continuous surveillance to prevent further dissemination of this antibiotic resistance gene. The presence of ISAba1 upstream of the blaADC was a determinant for cephalosporin resistance. However, the absence of this ISAba1-blaADC in some of the isolates may suggest other resistance mechanisms and need further investigation.

UR - http://www.scopus.com/inward/record.url?scp=84919724024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919724024&partnerID=8YFLogxK

U2 - 10.1099/jmm.0.082263-0

DO - 10.1099/jmm.0.082263-0

M3 - Article

VL - 64

SP - 53

EP - 58

JO - Journal of Medical Microbiology

JF - Journal of Medical Microbiology

SN - 0022-2615

IS - 1

ER -